Fortress Biotech, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cover
- Document And Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Summary of Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Non-Controlling Interests - Summary Of Non-controlling Interests in Consolidated Entities (Detail)

v3.5.0.2

Non-Controlling Interests - Summary Of Non-controlling Interests in Consolidated Entities (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015	Dec. 31, 2015
Noncontrolling Interest [Line Items]
NCI equity share			$ 31,226		$ 32,882
Net loss attributed to non-controlling interests	$ (3,911)	$ (243)	(8,349)	$ (722)	(5,455)
Non-controlling interests in consolidated entities	22,877		22,877		27,427
Avenue [Member]
Noncontrolling Interest [Line Items]
NCI equity share			(559)		6
Net loss attributed to non-controlling interests	(76)	(34)	(184)	(34)	(567)
Non-controlling interests in consolidated entities	(743)		(743)		(561)
Coronado SO Co, Inc [Member]
Noncontrolling Interest [Line Items]
NCI equity share			(217)		23
Net loss attributed to non-controlling interests	(5)	(70)	(10)	(230)	(240)
Non-controlling interests in consolidated entities	(227)		(227)		(217)
Mustang Therapeutics, Inc [Member]
Noncontrolling Interest [Line Items]
NCI equity share			(350)		14
Net loss attributed to non-controlling interests	(89)	(41)	(159)	(267)	(373)
Non-controlling interests in consolidated entities	(509)		(509)		(359)
Checkpoint Therapeutics, Inc [Member]
Noncontrolling Interest [Line Items]
NCI equity share			33,139		32,760
Net loss attributed to non-controlling interests	(3,476)	$ (98)	(7,513)	$ (191)	(3,855)
Non-controlling interests in consolidated entities	25,626		25,626		28,905
JMC [Member]
Noncontrolling Interest [Line Items]
NCI equity share			(288)		79
Net loss attributed to non-controlling interests	(108)		(229)		(420)
Non-controlling interests in consolidated entities	(517)		(517)		$ (341)
Helocyte [Member]
Noncontrolling Interest [Line Items]
NCI equity share			(499)
Net loss attributed to non-controlling interests	(157)		(254)
Non-controlling interests in consolidated entities	$ (753)		$ (753)

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(22))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(24))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name:	us-gaap_MinorityInterest
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_MinorityInterestLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4568740-111683

+ Details

Name:	us-gaap_MinorityInterestPeriodIncreaseDecrease
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of Net Income (Loss) attributable to noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591551-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684

+ Details

Name:	us-gaap_NetIncomeLossAttributableToNoncontrollingInterest
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=fbio_AvenueMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=fbio_CoronadoSoCoIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=fbio_MustangTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=fbio_CheckpointTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=fbio_JmcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=fbio_HelocyteMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: